Trial intelligence / Profile preview

Eviprostat N for moderate LUTS associated with benign prostatic hyperplasia

2004-002901-57Phase 4Completed

Sponsor
Evers-Pharma
Start
Jul 2005
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in benign prostatic hyperplasia (BPH) comparing Eviprostat N with Placebo (2 arms). Started Jul 2005; status: completed.

02

Drugs

Eviprostat N
03

Conditions

benign prostatic hyperplasia (BPH)

Beyond the preview

Go deeper on 2004-002901-57.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-002901-57.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call